Touch the screen or click to continue...
Checking your browser...
sumyarn.pages.dev

Kornelia polyak biography books

          We asked experts in cancer research to identify the most influential publications of the last two years.

          The book also contains chapters covering the many experimental approaches that have been used in this field, including transplantation, genetic engineering, RNA....

          Kornelia Polyak, MD, PhD

        1. Heterogeneity and transcriptional drivers of triple-negative breast cancer.

          Cell Rep. 2023 Dec 26; 42(12):113564. View in:Pubmed

        2. Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progression. Proc Natl Acad Sci U S A. 2023 Dec 05; 120(49):e2316763120.

          This collection from Cold Spring Harbor Perspectives in Biology reviews our understanding of mammary gland development, physiology, and tumor formation.

        3. This collection from Cold Spring Harbor Perspectives in Biology reviews our understanding of mammary gland development, physiology, and tumor formation.
        4. Breast cancer is a heterogeneous disease composed of multiple different subtypes with distinct molecular features and clinical behavior (1).
        5. The book also contains chapters covering the many experimental approaches that have been used in this field, including transplantation, genetic engineering, RNA.
        6. It is a must-read for everyone who wants to understand tumor evolution.
        7. CSHL Press publishes monographs, technical manuals, handbooks, review volumes, conference proceedings, scholarly journals and videotapes.

          8. View in:Pubmed

        8. Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer. Mol Cancer Ther. 2023 Nov 01; 22(11):1304-1318. View in:Pubmed

        9. HATS off to KAT6A/B inhibitors: A new way to target estrogen-receptor-positive breast cancer.

          Cell Chem Biol. 2023 10 19; 30(10):1183-1185. View in:Pubmed

        10. Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts.

          It is a must-read for everyone who wants to understand tumor evolution.

          Cancer Cell. 2023 Jul 10; 41(7):1381. View in:Pubmed

        11. A convolutional neural network STIFMap reveals associations between stromal stiffness and EMT in breast cancer. Nat Commun. 2023 06 15; 14(